Manhattan Scientifics, Inc.
MHTX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $50 | $50 | $50 |
| % Growth | -100% | 0% | 0% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$1 | $50 | $50 | $50 |
| % Margin | – | 100% | 100% | 100% |
| R&D Expenses | $10 | $11 | $10 | $11 |
| G&A Expenses | $693 | $718 | $727 | $714 |
| SG&A Expenses | $693 | $718 | $727 | $714 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | $0 | $0 | $0 |
| Operating Expenses | $702 | $729 | $737 | $725 |
| Operating Income | -$703 | -$679 | -$687 | -$675 |
| % Margin | – | -1,358% | -1,374% | -1,350% |
| Other Income/Exp. Net | -$462 | -$2,051 | -$2,952 | $4,989 |
| Pre-Tax Income | -$1,165 | -$2,730 | -$3,639 | $4,314 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,165 | -$2,730 | -$3,639 | $4,314 |
| % Margin | – | -5,460% | -7,278% | 8,628% |
| EPS | -0.002 | -0.005 | -0.007 | 0.008 |
| % Growth | 57.1% | 24.6% | -184.4% | – |
| EPS Diluted | -0.002 | -0.005 | -0.007 | 0.007 |
| Weighted Avg Shares Out | 559,281 | 559,281 | 559,281 | 558,322 |
| Weighted Avg Shares Out Dil | 559,281 | 559,281 | 559,281 | 593,051 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $21 | $26 | $25 |
| Depreciation & Amortization | $1 | $3 | $2 | $2 |
| EBITDA | -$1,164 | -$2,706 | -$3,611 | $4,341 |
| % Margin | – | -5,412% | -7,222% | 8,682% |